Group 1 - The core viewpoint of the news is that Microelectrophysiology experienced a decline of 5.1% on September 4, with a stock price of 22.35 yuan per share and a total market capitalization of 10.518 billion yuan [1] - The company, Shanghai Microelectrophysiology Medical Technology Co., Ltd., was established on August 31, 2010, and went public on August 31, 2022. Its main business involves the research, development, production, and sales of innovative medical devices in the field of electrophysiological interventional diagnosis and ablation treatment [1] - The revenue composition of the company includes catheter products at 72.52%, other products at 19.55%, equipment products at 6.40%, and supplementary items at 1.52% [1] Group 2 - From the perspective of fund holdings, one fund under Bank of China holds Microelectrophysiology as a significant position. The fund, Bank of China CSI 1000 Index Enhanced A (019555), held 41,500 shares in the second quarter, accounting for 0.75% of the fund's net value, ranking as the fifth-largest holding [2] - The fund has a total scale of 80.3401 million yuan and has achieved a year-to-date return of 26.6%, ranking 1444 out of 4222 in its category. Over the past year, it has returned 62.72%, ranking 1154 out of 3789 [2] - The fund manager, Yao Jin, has been in the position for 1 year and 268 days, with the fund's total assets amounting to 18.6 million yuan. The best return during his tenure is 50.4%, while the worst return is 2.5% [3]
微电生理股价跌5.1%,中银基金旗下1只基金重仓,持有4.15万股浮亏损失4.99万元